Cargando…
826. Decision to Treat Pneumocystis Jirovecii Pneumonia by Combining Molecular Diagnostics and Patient Specific Factors
BACKGROUND: Pneumocystis jirovecii pneumonia (PJP) diagnosis on immunocompromised patients with or without HIV has changed over time. Molecular methods have substituted microscopic methods that can be subjective, labor intensive, and require expertise. Additionally, they can be falsely negative in p...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677914/ http://dx.doi.org/10.1093/ofid/ofad500.871 |